The Economic Impact of Delaying Rare Diseases Diagnosis
A new study reveals that timely diagnosis can shorten or eliminate the diagnostic odyssey and reduce the cost impact of rare diseases.
Read MorePosted by Andy Lundin | Sep 15, 2023 | Miscellaneous |
A new study reveals that timely diagnosis can shorten or eliminate the diagnostic odyssey and reduce the cost impact of rare diseases.
Read MorePosted by Andy Lundin | Sep 15, 2023 | Colorectal |
Multiple novel mRNA biomarkers were identified for potential integration into pivotal FDA premarket approval clinical trial.
Read MorePosted by Andy Lundin | Sep 15, 2023 | Disease States |
Researchers led the creation of evidence-based consensus guidelines for genetic testing and counseling for patients with ALS.
Read MorePosted by Andy Lundin | Sep 14, 2023 | Sequencing Systems |
The Jackson Lab for Genomic Medicine is offering a clinical whole genome sequencing test to improve the diagnostic power of sequencing.
Read MorePosted by Andy Lundin | Sep 12, 2023 | Allergy & Autoimmune |
Researchers from the University of Houston are working to bring AI into the diagnostic picture for Lupus Nephritis.
Read More